Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001549595-24-000133

Chief Legal Officer sold 3,290 shares at $25.00 ($82,250)

  • Chief Legal Officer acquired 3,290 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ring Christine · Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-10-14 Exercise or conversion : show line 1 in the form 10b5-1 +3,290 $9.57 $31,485 27,882 D
2024-10-14 Sale : show line 2 in the form 10b5-1 −3,290 $25.00 $82,250 24,592 D
Open-market sales · 3,290 sh · avg $25.00 · $82,250

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-10-14 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (right to buy) −3,290 99,679 D
Loading xslF345X05/wk-form4_1728998177.xml…